Wird geladen...
Monitoring of Measurable Residual Disease in Multiple Myeloma by Multiparametric Flow Cytometry
Recent interest in high sensitivity multiple myeloma (MM) measurable residual disease (MRD) testing is a direct consequence of the high-quality responses achieved using novel therapeutic agents and better treatment strategies. Traditional diagnostic measures such as immunohistochemistry and morpholo...
Gespeichert in:
| Veröffentlicht in: | Curr Protoc Cytom |
|---|---|
| Hauptverfasser: | , |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
2019
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6788635/ https://ncbi.nlm.nih.gov/pubmed/31608132 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cpcy.63 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|